Karyopharm Therapeutics (KPTI) Change in Receivables (2019 - 2026)
Karyopharm Therapeutics (KPTI) posted Change in Receivables of -$5.7 million for Q4 2025, compared with -$1.01 million a year earlier.
Powered by 
Analysis
Karyopharm Therapeutics (KPTI) Change in Receivables (2019 - 2026) Analysis & Trends
For FY2025, Karyopharm Therapeutics' Change in Receivables came in at -$4.59 million.
- In prior years, Karyopharm Therapeutics' Change in Receivables was $3.8 million in FY2024, -$20.12 million in FY2023, $5.08 million in FY2022 (-47.1%) and $9.62 million in FY2021 (+91.6%).
- The Q4 2025 figure stands as the lowest quarterly Change in Receivables since Q3 2024.
- The strongest year-over-year quarter for Change in Receivables in the past five years was Q3 2022, with growth of 358.6%; the weakest was Q4 2022, with a decline of 96.4%.
- According to Business Quant data, Change in Receivables for the three prior quarters was -$1.06 million (Q3 2025), -$2.31 million (Q2 2025) and $4.48 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -188.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -312.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 108.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -52.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Karyopharm Therapeutics | 578,759.99 | -265.00 Mn | 32.35 Mn | 6.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.51 Mn |
| Mar 31, 2026 | -2.82 Mn |
| Dec 31, 2025 | -5.70 Mn |
| Sep 30, 2025 | -1.06 Mn |
| Jun 30, 2025 | -2.31 Mn |
| Mar 31, 2025 | 4.48 Mn |
| Dec 31, 2024 | -1.01 Mn |
| Sep 30, 2024 | -6.22 Mn |
| Jun 30, 2024 | 6.91 Mn |
| Mar 31, 2024 | 4.12 Mn |
| Dec 31, 2023 | -10.96 Mn |
| Sep 30, 2023 | 5.64 Mn |
| Jun 30, 2023 | -2.92 Mn |
| Mar 31, 2023 | -11.89 Mn |
| Dec 31, 2022 | 135,000.00 |
| Sep 30, 2022 | 3.97 Mn |
| Jun 30, 2022 | -1.51 Mn |
| Mar 31, 2022 | 2.50 Mn |
| Dec 31, 2021 | 3.75 Mn |
| Sep 30, 2021 | 865,000.00 |
API Access
Karyopharm Therapeutics Change in Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-receivables&ticker=KPTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-receivables", "ticker": "KPTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-receivables&ticker=KPTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();